Health
Pfizer, BioNTech start testing COVID-19 vaccine in pregnant women – Reuters
Pfizer Inc and BioNTech SE have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy…
CHICAGO, Feb 18 (Reuters) – Pfizer Inc and BioNTech SE have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women, the companies said on Thursday.
Pregnant women are at higher risk of developing severe COVID-19, and many public health officials have recommended some women in high-risk professions take coronavirus vaccines even without proof they are safe for them.
Last week, the U.S. National Institutes of…
-
Noosa News20 hours agoLuxury caravan manufacturer Zone RV collapses into administration
-
General21 hours agoWoman in her 20s dies after dog attack in Western Australia’s north
-
General8 hours agoBoard stacking allegations as RACP directors call snap meeting
-
General20 hours agoCase against teens charged over Adelaide shopping centre stabbing could move to adult court